Siliang Wang
Shanghai, 201203, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
AR-targeted therapies sensitize prostate cancer to cuproptosis by transcriptionally activating FDX1.
AR-targeted therapies sensitize prostate cancer to cuproptosis by transcriptionally activating FDX1.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 01, 2026
Unravelling the Mechanism of Methylophiopogonanone A Against Esophageal Squamous Cell Carcinoma Based on Network Pharmacology and Molecular Docking.
Journal: Current cancer drug targets
Published: February 20, 2025
High antigen-presenting CAF levels correlate with reduced glycosaminoglycan biosynthesis-heparan sulfate/heparin metabolism in immune cells and poor prognosis in esophageal squamous cell carcinoma: Insights from bulk and single-cell transcriptome profiling.
Journal: International journal of biological macromolecules
Published: October 06, 2024
AKR1B1-dependent fructose metabolism enhances malignancy of cancer cells.
Journal: Cell death and differentiation
Published: May 12, 2024
Unveiling the methionine cycle: a key metabolic signature and NR4A2 as a methionine-responsive oncogene in esophageal squamous cell carcinoma.
Journal: Cell death and differentiation
Published: November 10, 2023
A new In Situ Oxidized 2D Layered MnBi2Te4 Cathode for High-Performance Aqueous Zinc-Ion Battery.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: August 16, 2023
Active post-transcriptional regulation and ACLY-mediated acetyl-CoA synthesis as a pivotal target of Shuang-Huang-Sheng-Bai formula for lung adenocarcinoma treatment.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 21, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026